Intuitive Surgical, Inc. $ISRG Shares Acquired by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,463 shares of the medical equipment provider’s stock after purchasing an additional 2,102 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $5,127,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC boosted its holdings in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares during the period. Schnieders Capital Management LLC. grew its position in shares of Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after buying an additional 268 shares in the last quarter. Avidian Wealth Enterprises LLC increased its stake in shares of Intuitive Surgical by 2.2% during the second quarter. Avidian Wealth Enterprises LLC now owns 1,010 shares of the medical equipment provider’s stock worth $549,000 after buying an additional 22 shares during the period. Finally, D.A. Davidson & CO. raised its holdings in Intuitive Surgical by 2.5% in the second quarter. D.A. Davidson & CO. now owns 13,863 shares of the medical equipment provider’s stock valued at $7,533,000 after acquiring an additional 339 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.2%

ISRG stock opened at $499.53 on Friday. The company has a market capitalization of $177.40 billion, a P/E ratio of 63.31, a PEG ratio of 3.88 and a beta of 1.65. The business has a 50 day simple moving average of $536.64 and a 200-day simple moving average of $510.37. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $608.16.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the firm earned $2.21 EPS. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

ISRG has been the topic of a number of recent analyst reports. Argus dropped their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Wells Fargo & Company increased their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Citigroup reaffirmed a “neutral” rating and set a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Finally, Truist Financial raised their target price on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $617.23.

Insider Activity

In other news, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the transaction, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 56,189 shares of company stock valued at $30,785,441. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.